Revolution Medicines, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Revolution Medicines, Inc. (RVMD) had Common Stock, Capital Shares Reserved for Future Issuance of 37.71 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-05
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 37.71M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 39.63M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 28.65M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 30.10M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 37.71M shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 39.63M shares 10-Q · filed 2026-05-06 | |
| 2025-12-31 | 28.65M shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 30.10M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 32.91M shares 10-Q · filed 2025-08-06 | |
| 2024-12-31 | 31.73M shares 10-K · filed 2026-02-25 | |
| 2024-09-30 | 30.31M shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 30.79M shares 10-Q · filed 2024-08-07 | |
| 2024-03-31 | 33.23M shares 10-Q · filed 2025-05-07 | 31.52M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 31.73M shares 10-Q · filed 2025-05-07 | 21.88M shares 10-K · filed 2024-02-26 |
| 2023-09-30 | 22.32M shares 10-Q · filed 2023-11-06 | |
| 2023-06-30 | 22.63M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 18.47M shares 10-Q · filed 2023-05-08 | |
| 2022-12-31 | 17.77M shares 10-K · filed 2024-02-26 | |
| 2022-09-30 | 17.98M shares 10-Q · filed 2022-11-07 | |
| 2022-06-30 | 18.11M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 18.34M shares 10-Q · filed 2022-05-09 | |
| 2021-12-31 | 13.97M shares 10-K · filed 2023-02-27 | |
| 2021-09-30 | 14.12M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 14.20M shares 10-Q · filed 2021-08-11 | |
| 2021-03-31 | 14.34M shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 10.51M shares 10-K · filed 2022-02-28 | |
| 2020-09-30 | 10.79M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 11.20M shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 11.21M shares 10-Q · filed 2020-05-14 | |
| 2019-12-31 | 45.32M shares 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |